Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Kidney stone management · Vermont | Kidney stone management · New York | |
|---|---|---|
| Surgeons, 2024 | 10 | 134 |
| Medicare fee-for-service cases | 397 | 7,123 |
| Growth since 2019 (Medicare FFS) | +2.4%/yr | −2.3%/yr |
| Forecast cases (Medicare FFS) | 810 in 2030 | 7,020 in 2030 |
| Forecast growth | +13%/yr to 2030 | −0.2%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 3.5 | 4.0 |
| Medicare Advantage share | 35% | 57% |
| Out of hospital | 0% (+0 pts since 2019) | 10% (−0 pts since 2019) |
| Cases per surgeon | 40 | 53 |
| Top 10 surgeons' share | 100% | 22% |
| Surgeons growing | 1 | 18 |
| New since the base year | 1 | 21 |
| Likely to stop billing it | 3 by 2026 | 26 by 2026 |
| Forecast miss, 1 year (procedure) | 3% | 3% |
| Company payments per surgeon | – | $742 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.